2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow gosuranemab: new trials by email Literature Review of gosuranemab trials Research Report on gosuranemab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease BIIB092, Placebo - Alzheimer's Disease | Phase 2 | Terminated | Biogen | 654 | 2018-05-03 | 2022-11-08 |
| Study of BIIB092 in Participants With Progressive Supranuclear Palsy BIIB092, Placebo - Supranuclear Palsy, Progressive | Phase 2 | Terminated | Biogen | 490 | 2017-06-01 | 2020-12-21 |
Alzheimer Disease (1) · Cognitive Dysfunction (1) · Supranuclear Palsy, Progressive (1)
Biogen (2)
Australia (2) · France (2) · Germany (2) · Italy (2) · Japan (2) · Spain (2) · United States (2) · Austria (1) · Canada (1) · Greece (1) · Poland (1) · Russia (1) · South Korea (1) · Sweden (1) · United Kingdom (1)
PMID 34385707, PMID 34736158, PMID 38012285, PMID 38825840
2016 (1), 2017 (1)